These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 33180564)

  • 1. Oral drugs used to treat persistent pulmonary hypertension of the newborn.
    Zhang W; Wu YE; Yang XY; Shi J; van den Anker J; Song LL; Zhao W
    Expert Rev Clin Pharmacol; 2020 Dec; 13(12):1295-1308. PubMed ID: 33180564
    [No Abstract]   [Full Text] [Related]  

  • 2. Current and Future Treatments for Persistent Pulmonary Hypertension in the Newborn.
    Pedersen J; Hedegaard ER; Simonsen U; Krüger M; Infanger M; Grimm D
    Basic Clin Pharmacol Toxicol; 2018 Oct; 123(4):392-406. PubMed ID: 29855164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of early adjunctive use of oral sildenafil and inhaled nitric oxide on the outcome of pulmonary hypertension in newborn infants. A feasibility study.
    Al Omar S; Salama H; Al Hail M; Al Rifai H; Bunahia M; El Kasem W; Siddiqui FJ; Dilawar M; Yassin H; Masud F; Mohamed A; Mansour A
    J Neonatal Perinatal Med; 2016 Sep; 9(3):251-9. PubMed ID: 27589542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide.
    Lakshminrusimha S; Mathew B; Leach CL
    Semin Perinatol; 2016 Apr; 40(3):160-73. PubMed ID: 26778236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of oral sildenafil for neonates with persistent pulmonary hypertension of newborn (PPHN): a prospective study in a tertiary care hospital.
    Kamran A; Rafiq N; Khalid A; Amin F; Kumari V; Shaikh AS; Tebha SS; Patel N
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6787-6793. PubMed ID: 33980104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of oral sildenafil in neonatal persistent pulmonary hypertension of non-cardiac causes.
    Sayed A; Bisheer N
    J Neonatal Perinatal Med; 2015; 8(3):215-20. PubMed ID: 26485555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy for life-threatening pulmonary hypertension in a premature infant: first report on bosentan use.
    Radicioni M; Bruni A; Camerini P
    Eur J Pediatr; 2011 Aug; 170(8):1075-8. PubMed ID: 21380943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of IV Sildenafil in the Treatment of Newborn Infants with, or at Risk of, Persistent Pulmonary Hypertension of the Newborn (PPHN): A Multicenter, Randomized, Placebo-Controlled Trial.
    Pierce CM; Zhang MH; Jonsson B; Iorga D; Cheruvu N; Balagtas CC; Steinhorn RH
    J Pediatr; 2021 Oct; 237():154-161.e3. PubMed ID: 34052232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of sildenafil in the treatment of persistent pulmonary hypertension of the newborn: a review of the literature.
    Iacovidou N; Syggelou A; Fanos V; Xanthos T
    Curr Pharm Des; 2012; 18(21):3034-45. PubMed ID: 22564297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superior vasodilation of human pulmonary vessels by vardenafil compared with tadalafil and sildenafil: additive effects of bosentan.
    Ried M; Neu R; Lehle K; Großer C; Szöke T; Lang G; Hofmann HS; Hoenicka M
    Interact Cardiovasc Thorac Surg; 2017 Aug; 25(2):254-259. PubMed ID: 28486684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of bosentan therapy in persistent pulmonary hypertension of the newborn.
    Maneenil G; Thatrimontrichai A; Janjindamai W; Dissaneevate S
    Pediatr Neonatol; 2018 Feb; 59(1):58-64. PubMed ID: 28735030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of sildenafil in an infant with persistent pulmonary hypertension secondary to lung and renal hypoplasia - a case report.
    Lavie-Nevo K; Harris KC; Ting JY
    BMC Pediatr; 2019 Nov; 19(1):416. PubMed ID: 31690278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral therapies for the treatment of pulmonary arterial hypertension: a population-based cost-minimization analysis.
    Dranitsaris G; Mehta S
    Appl Health Econ Health Policy; 2009; 7(1):43-59. PubMed ID: 19558194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Sildenafil Use In Neonates With Persistent Pulmonary Hypertension Of Newborn.
    Hussain AS; Ali R; Ahmed S; Naz F; Haroon A
    J Ayub Med Coll Abbottabad; 2017; 29(4):677-680. PubMed ID: 29331003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent pulmonary hypertension in the newborn: therapeutic effect of sildenafil.
    Cruz-Blanquel A; Espinosa-Oropeza A; Romo-Hernández G; Carrillo-Alarcón L; Ponce-Monter H; Ortiz MI
    Proc West Pharmacol Soc; 2008; 51():73-7. PubMed ID: 19544683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Utility of Sildenafil for Persistent Pulmonary Hypertension of the Newborn.
    Evers PD; Critser PJ; Cash M; Magness M; Hoelle S; Hirsch R
    Am J Perinatol; 2021 Dec; 38(14):1505-1512. PubMed ID: 32615617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPHN: is sildenafil the new nitric? A review of the literature.
    Spillers J
    Adv Neonatal Care; 2010 Apr; 10(2):69-74. PubMed ID: 20386371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk-benefit considerations when prescribing phosphodiesterase-5 inhibitors in children.
    Magee AG; Makhecha S; Bentley S
    Expert Opin Drug Saf; 2015 May; 14(5):633-42. PubMed ID: 25746065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of sildenafil and tadalafil on the enzyme- and transporter-inducing effects of bosentan and ambrisentan in LS180 cells.
    Weiss J; Theile D; Spalwisz A; Burhenne J; Riedel KD; Haefeli WE
    Biochem Pharmacol; 2013 Jan; 85(2):265-73. PubMed ID: 23219525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bosentan as Adjunctive Therapy for Persistent Pulmonary Hypertension of the Newborn: Results of the Randomized Multicenter Placebo-Controlled Exploratory Trial.
    Steinhorn RH; Fineman J; Kusic-Pajic A; Cornelisse P; Gehin M; Nowbakht P; Pierce CM; Beghetti M;
    J Pediatr; 2016 Oct; 177():90-96.e3. PubMed ID: 27502103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.